| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.45 | 0.1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |